Market Tracker

11/21 6:05pm ET

Theravance Inc (NASDAQ:THRX)

13.97
Data as of Nov 21
 -0.04 / -0.29%
Today’s Change
12.78
Today|||52-Week Range
32.88
-51.35%
Year-to-Date
THRX Regular Dividend: THRX began trading ex-dividend on 11/21/14. A $0.25 dividend will be paid to shareholders of record as of 11/25/14.

Today’s Trading

Previous close14.01
Today’s open14.30
Day’s range13.68 - 14.48
Volume663,574
Average volume (3 months)948,325
Market cap$1.6B
Dividend yield7.16%
Data as of 4:00pm ET, 11/21/2014

Growth & Valuation

Earnings growth (last year)-735.00%
Earnings growth (this year)+29.51%
Earnings growth (next 5 years)-167.64%
Revenue growth (last year)-96.50%
P/E ratioNM
Price/Sales767.43
Price/Book5.21

Competitors

 Today’s
change
Today’s
% change
LCILannett Company Inc-1.02-2.19%
CBPOChina Biologic Produ...-0.51-0.75%
AUXLAuxilium Pharmaceuti...+0.20+0.60%
GWPHGW Pharmaceuticals P...+0.03+0.04%
Data as of 4:00pm ET, 11/21/2014

Financials

Next reporting dateFebruary 5, 2015
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$4.8M
Annual profit (last year)-$170.7M
Net profit margin-3,587.66%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael W. Aguiar
Senior Vice President-
Operations
Frank C. Pasqualone
Corporate headquarters
South San Francisco, California

Forecasts